A Phase 2 Efficacy and Safety Study of Niraparib in Men with Metastatic Castration-resistant Prostate Cancer and DNA-Repair Anomalies
Clinical Trial Grant
Awarded By
Janssen Pharmaceutica, Inc.
Start Date
October 4, 2017
End Date
July 5, 2024
Awarded By
Janssen Pharmaceutica, Inc.
Start Date
October 4, 2017
End Date
July 5, 2024